Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 32

Results For "ABLE"

4630 News Found

Aurobindo Pharma signs MoU with Hare Krishna Charitable Foundation
Sustainability | April 22, 2022

Aurobindo Pharma signs MoU with Hare Krishna Charitable Foundation

A centralised kitchen which provides 5,000 breakfast meals per day is to be started at Perumallapuram, Kakinada, Andhra Pradesh


Dr. Reddy's launch Posaconazole delayed-release tablets in the US
Drug Approval | April 21, 2022

Dr. Reddy's launch Posaconazole delayed-release tablets in the US

The tablets are available in 100 mg strength in bottle count sizes of 60


Lupin receives tentative approval from USFDA for Tenofovir Alafenamide Tablets
Drug Approval | April 18, 2022

Lupin receives tentative approval from USFDA for Tenofovir Alafenamide Tablets

This product will be manufactured at Lupin’s Nagpur facility in India


Lupin receives approval from USFDA for Desvenlafaxine extended-release tablets 25 mg
Drug Approval | April 15, 2022

Lupin receives approval from USFDA for Desvenlafaxine extended-release tablets 25 mg

The product will be manufactured at Lupin’s facility in Goa, India


PhableCare raises Rs 187 crore in Series B funding
Startup | April 12, 2022

PhableCare raises Rs 187 crore in Series B funding

The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round


Pristyn Care’s new app enables location-based discovery of doctors
Startup | April 06, 2022

Pristyn Care’s new app enables location-based discovery of doctors

An upgraded, state-of-the-art integrated app, helps easy discovery of expert surgeons for convenient in-clinic or online consultation


Cipla Medpro South Africa partners with mAbxience for affordable cancer drugs
News | March 31, 2022

Cipla Medpro South Africa partners with mAbxience for affordable cancer drugs

The mAbxience partnership will enable Cipla to continue its ethos of ensuring equitable access to affordable, life-saving medication


Phablecare acquires Fused Training, a startup combating Type-1 Diabetes
Startup | March 31, 2022

Phablecare acquires Fused Training, a startup combating Type-1 Diabetes

Phablecare closed this acquisition for an undisclosed sum, betting on the start-up's holistic approach to Type 1 Diabetes management


FDI World Dental Federation releases statement on sustainable oral healthcare
Sustainability | March 31, 2022

FDI World Dental Federation releases statement on sustainable oral healthcare

It paves the way for an industry Code of Good Practice


Tarlige tablets approved in Japan for treatment of patients with neuropathic pain
Drug Approval | March 28, 2022

Tarlige tablets approved in Japan for treatment of patients with neuropathic pain

In May 2021, Daiichi Sankyo had submitted a supplemental new drug application (sNDA) for Tarlige tablets based on results from a phase 3 trial in patients with CNP